In addition to the marijuana story on HealthDay, CHR had quite a busy month of media contributions. In the January 16, 2019 issue of the Philadelphia Inquirer, writer Marie McCullough examined the drawbacks of minimal-stimulation IVF, or mini IVF. The in-depth article, titled “Why a gentler, less costly approach to IVF remains unpopular,” quoted Norbert Gleicher, MD, CHR’s Medical Director and Chief Scientist. Dr. Gleicher drew on Japan’s experience to explain how mini IVF reduces live birth chances with IVF: After Japan mostly switched to mini IVF, the country “lost two-thirds of its live birthrate. It went from 15 percent per IVF cycle to 5 percent. That’s the lowest rate in the world.”
Also in mid-January, Dr. Gleicher was featured in New York Times, in its Sunday Routine column. Because IVF requires precise timing for egg retrieval and embryo transfer, Dr. Gleicher usually spends weekend mornings seeing patients at CHR. The NYT column followed Dr. Gleicher on a Sunday after he completed consultations and procedures.
Finally, Reuters writer Lisa Rapaport interviewed Dr. Gleicher for an article on the risk of preterm births associated with IVF. Dr. Gleicher, whose editorial accompanying The Lancet article on the subject had just appeared, explained that a history of infertility itself, rather than the treatment, can be a contributing factor to preterm births. “What causes infertility can be associated with adverse genetic traits inherited by the next generation […] It will take several generations to get a better picture of the risks of IVF, and how these risks might differ based on parents’ unique characteristics,” said Dr. Gleicher.